CLINICAL_TRIALS
research
· 2008-10-10
Clinical Trial Update: Metastatic Advanced Pancreas Sorafenib [Phase 2]
Summary
This document provides an update on a Phase 2 trial of Sorafenib for pancreatic cancer (locally advanced/metastatic).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | Conditions: Locally Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN